218 related articles for article (PubMed ID: 8427659)
1. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
Shigetomi S; Kuchel O
Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
Kuchel OG; Shigetomi S
Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367
[TBL] [Abstract][Full Text] [Related]
3. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients.
Kuchel O; Shigetomi S
Hypertension; 1992 Jun; 19(6 Pt 2):634-8. PubMed ID: 1592460
[TBL] [Abstract][Full Text] [Related]
4. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
Vieira-Coelho MA; Pestana M; Soares-da-Silva P
Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic abnormalities in borderline essential hypertensive patients.
Shigetomi S; Buu NT; Kuchel O
Hypertension; 1991 Jun; 17(6 Pt 2):997-1002. PubMed ID: 1904403
[TBL] [Abstract][Full Text] [Related]
6. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans.
Goldstein DS; Stull R; Eisenhofer G; Gill JR
Clin Sci (Lond); 1989 May; 76(5):517-22. PubMed ID: 2498027
[TBL] [Abstract][Full Text] [Related]
8. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
[TBL] [Abstract][Full Text] [Related]
9. Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.
Williams M; Young JB; Rosa RM; Gunn S; Epstein FH; Landsberg L
J Clin Invest; 1986 Dec; 78(6):1687-93. PubMed ID: 3097077
[TBL] [Abstract][Full Text] [Related]
10. Derivation of urinary dopamine from plasma dopa.
Zimlichman R; Levinson PD; Kelly G; Stull R; Keiser HR; Goldstein DS
Clin Sci (Lond); 1988 Nov; 75(5):515-20. PubMed ID: 3151165
[TBL] [Abstract][Full Text] [Related]
11. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
Mars H
Trans Am Neurol Assoc; 1973; 98():241-5. PubMed ID: 4784941
[No Abstract] [Full Text] [Related]
12. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid.
Eldrup E; Møller SE; Andreasen J; Christensen NJ
Clin Sci (Lond); 1997 Apr; 92(4):423-30. PubMed ID: 9176043
[TBL] [Abstract][Full Text] [Related]
13. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
15. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension.
Gill JR; Grossman E; Goldstein DS
Hypertension; 1991 Nov; 18(5):614-21. PubMed ID: 1937664
[TBL] [Abstract][Full Text] [Related]
16. Urinary dopamine and renal handling of L-DOPA in fasted spontaneously hypertensive rats.
Dantonello TM; Küster E; Mühlbauer B
Kidney Blood Press Res; 1998; 21(6):438-44. PubMed ID: 9933829
[TBL] [Abstract][Full Text] [Related]
17. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
[TBL] [Abstract][Full Text] [Related]
18. A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.
Armando I; Nowicki S; Aguirre J; Barontini M
Am J Physiol; 1995 Jun; 268(6 Pt 2):F1087-92. PubMed ID: 7611449
[TBL] [Abstract][Full Text] [Related]
19. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
20. Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans.
Wolfovitz E; Grossman E; Folio CJ; Keiser HR; Kopin IJ; Goldstein DS
Clin Sci (Lond); 1993 May; 84(5):549-57. PubMed ID: 8504632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
